Abstract
The recent introduction of new rules for the involvement of general practitioners in clinical trials in Italy, and the less recent decentralization process, have affected clinical investigations and regulatory activity. Regulatory affairs professionals and clinical researchers have had to become acquainted with a new, more dynamic, and more flexible environment for clinical trials that still guarantees high-quality protection to trial subjects.
The regulatory environment for clinical trials in Italy has improved dramatically, supported by the authorities’ continuous effort to improve the rules. Italy now attracts more innovative investigations. We summarize when, how, and where decentralized or centralized control of clinical trials is exerted, when general practitioners can be involved, and the role of the National Monitoring Centre for Clinical Trials in producing state-of-the-art on-line registers of clinical trial reports.
We concluded that Italy has definitely left delays and bureaucracy behind, and is now ready to play a major role in clinical drug development and to provide an important contribution to innovative, original clinical investigations.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Bianchi L, Bianchi W, del Mastro S. Collaborazione Industria-Università Nella Ricerca Clinica. Cronache Farmaceutiche. 1995;4:205–210.
Bianchi W, del Mastro S, Ottolenghi L, Zaccarini P. Conducting Clinical Trials in Italy. Appl Clinical Trials. 1997;6(2):26–32.
Bianchi W, Alessi E. Sperimentazione clinica: una svolta storica. SIARnews. 1998;23:28–34.
Marini S, Scala E. Italy’s puzzle of local ethical and administrative approval. A CRO’s experience with clinical trial activation. Appl Clinical Trials. 1999; 8(11):40–45.
Venturini F, Alberti C, Alberti MP, Scroccaro G. Clinical trials in Italy: focus on the protocols submitted to Ethics Committees. J Clin Pharmacy Therapeutics. 2001;26:103–110.
Bonati M. Primary care is natural place for clinical research and practice. Br Med J. 2000;321:1529.
Nutting PA, Beasley JW, Werner JJ. Practice-based research networks answer primary care questions. JAMA. 1999;281:686–688.
White KL. Fundamental research at primary care level. Lancet. 2000;355:1904–1906.
Wilson S, Delaney C, Roalfe A, Roberts L, Redman V, Wearn AM, Hobbs FDR. Randomised controlled trials in primary care: case study. Br Med J. 2000;321:24–27.
Bianchi W. Una nuova pietra miliare per la sperimen-tazione clinica in Italia: il decreto 10 maggio 2001. SIARnews. 2001;35:25–28.
Crisculo D, Pisoni G, Bellucci A, Riva E. The new IND process in Italy: A 1998–2000 survey. Int J Pharma Med. 2001;15:241–243.
Directive 2001/20/EC of the European Parliament and of the Council of 4 April 2001 on the approximation of the laws, regulations and administrative provisions of the Member States relating to the implementation of good clinical practice in the conduct of clinical trials on medicinal products for human use. OJ L121, 1.5.2001 p.34/44.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Bianchi, W., Furlani, P., Alessi, T. et al. Clinical Trials: Focus on Italy. Ther Innov Regul Sci 36, 387–394 (2002). https://doi.org/10.1177/009286150203600218
Published:
Issue Date:
DOI: https://doi.org/10.1177/009286150203600218